Maravai LifeSciences Holdings Inc (MRVI)
7.665
-0.06
(-0.71%)
USD |
NASDAQ |
Apr 24, 16:00
7.675
+0.01
(+0.13%)
After-Hours: 16:10
Maravai LifeSciences Holdings Debt to Equity Ratio: 1.258 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.258 |
| September 30, 2023 | 1.011 |
| June 30, 2023 | 1.01 |
| March 31, 2023 | 1.010 |
| December 31, 2022 | 0.9674 |
| September 30, 2022 | 1.049 |
| June 30, 2022 | 1.159 |
| March 31, 2022 | 1.385 |
| December 31, 2021 | 1.682 |
| Date | Value |
|---|---|
| September 30, 2021 | 1.756 |
| June 30, 2021 | 2.746 |
| March 31, 2021 | 4.738 |
| December 31, 2020 | 6.040 |
| September 30, 2020 | -6.690 |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | 2.385 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-6.690
Minimum
Sep 2020
6.040
Maximum
Dec 2020
1.434
Average
1.258
Median
Dec 2023
Debt to Equity Ratio Benchmarks
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.487B |
| Total Liabilities (Quarterly) | 697.57M |
| Shareholders Equity (Quarterly) | 416.75M |
| Current Ratio | 8.002 |
| Net Debt Paydown Yield | 0.10% |